Efor and CVO Europe join forces to become the european leader in Life Sciences consulting

A strategic partnership

Efor Group continues its growth journey with the acquisition of CVO Europe, a recognized pioneer in life sciences consulting. This strategic alliance strengthens Efor’s commitment to the healthcare sector and accelerates its specialization by delivering a comprehensive offering to pharmaceutical, medical device, and biotechnology companies. This milestone marks a key turning point in Efor’s history, solidifying its position as a trusted partner for companies in the industry.

About CVO-Europe

For 25 years, CVO Europe has supported pharmaceutical and biotechnology industries with recognized expertise, especially among major accounts in France and across Europe. Founded in Lyon by Jérôme Tomaselli and Patrick Etievant, this life sciences consulting pioneer has distinguished itself as a leading French firm focused on regulatory compliance. Its presence also extends to Belgium and Switzerland, further strengthening its influence in the European market.

An enhanced and complementary offering

Through this acquisition, Efor expands its service portfolio and complements its core expertise in quality and regulatory affairs. Integrating CVO Europe enriches the offering with specialized skills in production tool validation, training, and system audits. This synergy creates a solid platform capable of addressing the growing challenges of the healthcare sector, both nationally and internationally.

A clear European ambition

This partnership is part of an ambitious growth strategy aimed at positioning Efor as a key reference player in Europe. Leveraging combined resources and expertise, the group is committed to supporting its clients in innovation, compliance, and digital transformation projects within an increasingly demanding regulatory environment.